L

LENAPHARM (Private limited company)

BE 0556.895.014 Active ●Boulevard Général Jacques 42, 1050 Ixelles

LENAPHARM is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0556.895.014. It was founded on 28-07-2014. Its registered office is in Ixelles. Its main activity is: Financial service activities, except insurance and pension funding. Its annual accounts for 2024 report equity of € 119 486 and a profit of € 6 522. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). Its annual accounts for the 2025 financial year have not been filed, although the legal deadline has passed.

Information last updated on 09-10-2026.

Company information

Status
Active
Enterprise number
BE 0556.895.014
VAT registered
No
Founded
28-07-2014
Latest accounts
2024
Employees
-
Region
Brussels-Capital
Establishments
1
Filing record
2025 accounts not filed
Peppol e-invoicing
Registered
Registered office
Boulevard Général Jacques 42, 1050 Ixelles
Main activity
Financial service activities, except insurance and pension funding
NACE activities
64210 Activités de société holding
68201 Location et exploitation de biens immobiliers résidentiels propres ou loués, sauf logements sociaux
6820301 Location d'immeubles non résidentiels ( bureaux, espaces commerciaux, halls d'exposition, etc)
7010001 Activités de gestion de holdings : intervention dans la gestion journalière, représentation des entreprises sur base de la possession ou du contrôle du capital social, etc
7020001 Conseils et assistance aux entreprises et aux services publics en matière de planification, d'organisation, de recherche du rendement, de contrôle, d'information du gestion, etc.

Key figures of LENAPHARM

2024202320222021
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 6 522+13 %€ 5 760-73 %€ 21 110+373 %€ 4 460
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 119 486+6 %€ 112 963+5 %€ 107 203+25 %€ 86 093
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 1 063 674+3 %€ 1 037 096+7 %€ 973 542-15 %€ 1 140 955
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 59 355+272 %€ 15 966-58 %€ 37 994+80 %€ 21 050
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Ixelles.

CompanyTown
D'Ieteren Automotive SA/NV 1050 Ixelles
Watt Matters 1050 Ixelles
ECONOCOM GROUP 1050 Ixelles
D'Ieteren Group 1050 Ixelles
Devaux, Roland Associés 1050 Bruxelles
B'Linea 1050 Ixelles
TEXAF 1050 Bruxelles
Société Centrale de Gestion 1050 Ixelles
Looking for more information about LENAPHARM?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is LENAPHARM still active? Yes. The Crossroads Bank for Enterprises lists LENAPHARM as active.

What is the VAT number of LENAPHARM? LENAPHARM is not registered for VAT. Its enterprise number is 0556.895.014.

When was LENAPHARM founded? LENAPHARM was founded on 28-07-2014.

What is the address of LENAPHARM? The current registered office of LENAPHARM is Boulevard Général Jacques 42, 1050 Ixelles.

When did LENAPHARM last file annual accounts? The latest annual accounts of LENAPHARM were filed on 18-10-2025.

Does LENAPHARM file its annual accounts on time? The annual accounts of LENAPHARM for the 2025 financial year have not been filed, although the legal deadline has passed.

Is LENAPHARM financially healthy? Addrly gives LENAPHARM a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is LENAPHARM profitable? The annual accounts of LENAPHARM for 2024 show a profit of € 6 522.

What is the equity of LENAPHARM? The equity of LENAPHARM was € 119 486 at the close of the 2024 financial year.

Who are the directors of LENAPHARM? The annual accounts of LENAPHARM record 1 mandate. The name, role and dates are visible with a free account.

Can LENAPHARM receive Peppol e-invoices? Yes. LENAPHARM is registered on the Peppol network and can receive structured electronic invoices.

What does LENAPHARM do? The main activity of LENAPHARM is: Financial service activities, except insurance and pension funding.

Sources

How Addrly builds and refreshes this data